Rosanna Ricafort
Rosanna Ricafort is a highly accomplished pharmaceutical professional with extensive experience in leadership and technical support.
She has over 9 years of experience as a board-certified Pediatric Hematologist/Oncologist and has been associated with a leading academic institution and NCI-designated cancer center.
Rosanna is known for her program building skills, leadership in clinical trials, and a patient-centered approach towards advancing oncology through research.
She holds a Doctor of Medicine (MD) degree from Gerstner Sloan-Kettering Graduate School of Biomedical Sciences at Memorial Sloan-Kettering Cancer Center.
Her educational background includes studies at St. Christopher's Hospital for Children and Mount Sinai School of Medicine of New York University.
Currently, Rosanna serves as the Vice President of Cell Therapy Clinical Development at Bristol-Myers Squibb, where she previously held various key roles like Clinical Team Lead and Program Lead in the Hematology-Oncology field.
Prior to her current position, she was the Immuno-Oncology Hematology Disease Area Head at Bristol-Myers Squibb and also worked as the US Therapeutic Area Medical Director at Celgene.
Rosanna Ricafort has previously served as a Pediatric Oncologist at Montefiore Medical Center and was a Fellow at Memorial Sloan Kettering Cancer Center.